• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

糖尿病肾病——Ⅰ型和Ⅱ型之间存在差异吗?

Diabetic nephropathy--are there differences between type I and type II?

作者信息

Ritz E, Hasslacher C, Tschöpe W

机构信息

Department of Internal Medicine, Ruperto Karola University, Heidelberg, FRG.

出版信息

Miner Electrolyte Metab. 1990;16(1):69-72.

PMID:2182996
Abstract

It has commonly been assumed that the renal risk in type II diabetes is markedly lower than in type I diabetes since only approximately 5% of the former but 40% of the latter experience renal failure. Based on our observations in the diabetes outpatient department of the University of Heidelberg, we conclude that the cumulative risk of developing proteinuria for the nonproteinuric type II diabetic and the cumulative risk of developing renal failure for the proteinuric type II diabetic are comparable with the respective risks of the type I diabetic. This observation is noteworthy since there is no uncontroversial evidence of hyperfiltration in early type II diabetes. Type II diabetes may be an interesting model for testing the hyperfiltration theory.

摘要

人们通常认为,II型糖尿病的肾脏风险明显低于I型糖尿病,因为前者只有约5%会出现肾衰竭,而后者有40%会出现肾衰竭。基于我们在海德堡大学糖尿病门诊的观察,我们得出结论,非蛋白尿性II型糖尿病患者发生蛋白尿的累积风险以及蛋白尿性II型糖尿病患者发生肾衰竭的累积风险,与I型糖尿病患者的相应风险相当。这一观察结果值得注意,因为在早期II型糖尿病中,尚无关于超滤的无争议证据。II型糖尿病可能是检验超滤理论的一个有趣模型。

相似文献

1
Diabetic nephropathy--are there differences between type I and type II?糖尿病肾病——Ⅰ型和Ⅱ型之间存在差异吗?
Miner Electrolyte Metab. 1990;16(1):69-72.
2
Nephropathy in type II diabetes.2型糖尿病肾病
Exp Clin Endocrinol Diabetes. 1997;105 Suppl 2:80-2. doi: 10.1055/s-0029-1211805.
3
[The kidney as a target organ in diabetic patients with arterial hypertension].[肾脏作为动脉高血压糖尿病患者的靶器官]
Drugs. 2003;63 Spec No 1:31-7.
4
[Improved prognosis of Type I and Type II diabetics with nephropathy].
Med Klin (Munich). 1990 Nov 15;85(11):643-6.
5
[Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].2型糖尿病合并糖尿病肾病患者的血脂异常与心血管风险
Nefrologia. 2002;22 Suppl 1:51-8.
6
Gustatory sweating in diabetes mellitus.糖尿病中的味觉性出汗。
Diabet Med. 1996 Dec;13(12):1033-7. doi: 10.1002/(SICI)1096-9136(199612)13:12<1033::AID-DIA280>3.0.CO;2-B.
7
[Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors].[非胰岛素依赖型糖尿病合并糖尿病肾病患者发生慢性肾衰竭的风险以及持续性蛋白尿和动脉高血压的阶段:临床因素的作用]
Ter Arkh. 2000;72(6):52-4.
8
Mouse models of diabetic nephropathy.糖尿病肾病的小鼠模型
J Am Soc Nephrol. 2005 Jan;16(1):27-45. doi: 10.1681/ASN.2004080648. Epub 2004 Nov 24.
9
[Diabetes mellitus, hypertension and kidney].[糖尿病、高血压与肾脏]
Vnitr Lek. 2008 May;54(5):499-504, 507.
10
Nonproteinuric diabetic nephropathy: when diabetics don't read the textbook.非蛋白尿性糖尿病肾病:当糖尿病患者不按课本做时。
Med Clin North Am. 2013 Jan;97(1):53-8. doi: 10.1016/j.mcna.2012.10.006. Epub 2012 Nov 27.

引用本文的文献

1
Protective Effects of Green Tea Extract against Hepatic Tissue Injury in Streptozotocin-Induced Diabetic Rats.绿茶提取物对链脲佐菌素诱导糖尿病大鼠肝组织损伤的保护作用。
Evid Based Complement Alternat Med. 2012;2012:740671. doi: 10.1155/2012/740671. Epub 2012 Feb 27.
2
Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus.白细胞介素-1受体拮抗剂等位基因(IL1RN*2)与糖尿病肾病相关。
Hum Genet. 1996 Mar;97(3):369-74. doi: 10.1007/BF02185776.
3
Albumin excretion rate levels in non-diabetic offspring of NIDDM patients with and without nephropathy.
非胰岛素依赖型糖尿病(NIDDM)患者有或无肾病的非糖尿病后代的白蛋白排泄率水平。
Diabetologia. 1995 Oct;38(10):1218-22. doi: 10.1007/BF00422372.